20Jan 2021
Prostate cancer C5a receptor expression and augmentation of cancer cell proliferation, invasion, and PD‐L1 expression by C5a

Prostate cancer C5a receptor expression and augmentation of cancer cell proliferation, invasion, and PD‐L1 expression by C5a

The treatment of castration‐resistant prostate cancer (CRPC) is a urological issue. Recent studies have revealed cancer promotion via the C5a–C5a receptor (C5aR) system. To establish a new therapeutic target for CRPC, we investigated an association of the system with CRPC progression and evasion from the antitumor immune responses.

  • #urology

Like

Save

Share